1.36
NanoViricides Inc stock is traded at $1.36, with a volume of 114.45K.
It is down -0.73% in the last 24 hours and down -6.21% over the past month.
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could provide functional cure for HIV/AIDS. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes virus infections; and eye drops against viral infections of the external eye, as well as involved in the other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
See More
Previous Close:
$1.37
Open:
$1.38
24h Volume:
114.45K
Relative Volume:
0.67
Market Cap:
$21.86M
Revenue:
-
Net Income/Loss:
$-8.29M
P/E Ratio:
-1.9429
EPS:
-0.7
Net Cash Flow:
$-6.47M
1W Performance:
-6.21%
1M Performance:
-6.21%
6M Performance:
+22.52%
1Y Performance:
-8.72%
NanoViricides Inc Stock (NNVC) Company Profile
Name
NanoViricides Inc
Sector
Industry
Phone
203-937-6137
Address
1 Controls Drive, Shelton, CT
Compare NNVC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NNVC
NanoViricides Inc
|
1.36 | 23.88M | 0 | -8.29M | -6.47M | -0.70 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-11-15 | Initiated | Midtown Partners | Strong Buy |
NanoViricides Inc Stock (NNVC) Latest News
Using data filters to optimize entry into NanoViricides Inc.Weekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Can NanoViricides Inc. (NV3P) stock attract ESG investmentsSell Signal & Fast Exit and Entry Strategy Plans - newser.com
Understanding NanoViricides Inc.’s price movementWeekly Stock Recap & Free Community Consensus Stock Picks - newser.com
Is NanoViricides Inc. stock in buy zone after pullbackMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
Exit strategy if you’re trapped in NanoViricides Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Why global investors buy NanoViricides Inc. stockTake Profit & Weekly Breakout Watchlists - newser.com
News impact scoring models applied to NanoViricides Inc.Market Performance Report & Verified Momentum Watchlists - newser.com
Is NanoViricides Inc. (NV3P) stock a safe buy pre earnings2025 Winners & Losers & Free Safe Capital Growth Stock Tips - newser.com
Detecting price anomalies in NanoViricides Inc. with AIWeekly Gains Report & Reliable Intraday Trade Plans - newser.com
Using Bollinger Bands to evaluate NanoViricides Inc.July 2025 Review & Reliable Price Breakout Alerts - newser.com
How to read the order book for NanoViricides Inc.2025 Volatility Report & Daily Oversold Bounce Ideas - newser.com
NanoViricides, Inc. Has Filed its Annual Report - Barnstable Patriot
Is NanoViricides Inc. (NV3P) stock undervalued by metricsExit Point & Risk Controlled Swing Alerts - newser.com
Trend analysis for NanoViricides Inc. this weekPortfolio Value Report & Safe Entry Momentum Tips - newser.com
NanoViricides Inc (AMEX: NNVC) stock has achieved $1.4600 in the past week - fostersleader.com
What makes NanoViricides Inc. stock appealing to growth investorsJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com
What machine learning models say about NanoViricides Inc.Gap Down & Weekly Market Pulse Alerts - newser.com
How NanoViricides Inc. (NV3P) stock trades after rate cutsJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Is NanoViricides Inc. forming a bottoming base2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
NanoViricides (NYSE:NNVC) Trading Up 0.7% – Here’s What Happened - Defense World
NanoViricides extends executive contracts and amends credit line - Investing.com
NanoViricides extends executive contracts and amends credit line By Investing.com - Investing.com Canada
NanoViricides Inc Stock (NNVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):